Conversion of big endothelin-1 to 21-residue endothelin-1 is essential for expression of full vasoconstrictor activity: structure-activity relationships of big endothelin-1
- PMID: 2473327
- DOI: 10.1097/00005344-198900135-00003
Conversion of big endothelin-1 to 21-residue endothelin-1 is essential for expression of full vasoconstrictor activity: structure-activity relationships of big endothelin-1
Abstract
The vasoconstrictor activities of porcine big endothelin-1 (big ET-1), a 39-residue intermediate predicted from cDNA sequence analysis, and of its shorter derivative, big ET-1 [1-25], were characterized in vitro by measuring the contraction of porcine coronary artery strips. Synthetic big ET-1 [1-39] and big ET-1 [1-25] induced a slow developing, long-lasting, and strong vasoconstriction as in the case of 21-residue ET-1. However, the contractile molar potencies of big ET-1 [1-39] and big ET-1 [1-25] were approximately 140- and 50-fold lower than that of ET-1, respectively. These results indicate that the conversion of big ET-1 to "mature" ET-1 is essential for the expression of the full vasoconstrictor activity, suggesting the physiological importance of the unusual proteolytic processing catalyzed by the putative "ET converting enzyme."
Similar articles
-
Pepsin, an aspartic protease, converts porcine big endothelin to 21-residue endothelin.Biochem Biophys Res Commun. 1990 Jan 15;166(1):436-42. doi: 10.1016/0006-291x(90)91964-t. Biochem Biophys Res Commun. 1990. PMID: 2105722
-
Structure-activity relationships of endothelin: importance of the C-terminal moiety.Biochem Biophys Res Commun. 1988 Nov 15;156(3):1182-6. doi: 10.1016/s0006-291x(88)80757-5. Biochem Biophys Res Commun. 1988. PMID: 3056409
-
Receptor binding and vasoconstrictor activity of big endothelin.Eur J Pharmacol. 1990 Feb 6;176(2):225-8. doi: 10.1016/0014-2999(90)90532-b. Eur J Pharmacol. 1990. PMID: 2155800
-
Endothelin: a review of its effects and possible mechanisms of action.Neurochem Res. 1990 Apr;15(4):407-17. doi: 10.1007/BF00969926. Neurochem Res. 1990. PMID: 2167457 Review.
-
Endothelin and vasoactive peptides: new cardiovascular mediators.J Vet Pharmacol Ther. 1994 Dec;17(6):420-5. doi: 10.1111/j.1365-2885.1994.tb00272.x. J Vet Pharmacol Ther. 1994. PMID: 7707486 Review.
Cited by
-
Endothelium-dependent vascular responses. Mediators and mechanisms.J Clin Invest. 1989 Nov;84(5):1373-8. doi: 10.1172/JCI114309. J Clin Invest. 1989. PMID: 2681265 Free PMC article. Review. No abstract available.
-
Endothelin receptor antagonists.World J Urol. 2005 Feb;23(1):19-27. doi: 10.1007/s00345-004-0478-9. Epub 2005 Jan 15. World J Urol. 2005. PMID: 15654644 Review.
-
The nitric oxide-endothelin-1 connection.Heart Fail Rev. 2003 Jan;8(1):107-15. doi: 10.1023/a:1022155206928. Heart Fail Rev. 2003. PMID: 12652164 Review.
-
Sensitization to acute procedural pain in pediatric sickle cell disease: modulation by painful vaso-occlusive episodes, age, and endothelin-1.J Pain. 2012 Jul;13(7):656-65. doi: 10.1016/j.jpain.2012.04.001. Epub 2012 May 24. J Pain. 2012. PMID: 22633685 Free PMC article.
-
Endothelin and the renal microcirculation.Semin Nephrol. 2015 Mar;35(2):145-55. doi: 10.1016/j.semnephrol.2015.02.004. Semin Nephrol. 2015. PMID: 25966346 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources